← Encompass Health Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | $247.6m |
$256.3m
+3.51%
|
$292.3m
+14.05%
|
$358.7m
+22.72%
|
$284.2m
-20.77%
|
$412.2m
+45.04%
|
$271.0m
-34.26%
|
$352.0m
+29.89%
|
$455.7m
+29.46%
|
$566.2m
+24.25%
|
— | |
| Net Income (Loss) Available to Common Stockholders, Basic | $247.6m |
$256.3m
+3.51%
|
$375.4m
+46.47%
|
$445.8m
+18.75%
|
$368.8m
-17.27%
|
$517.2m
+40.24%
|
$269.8m
-47.83%
|
$349.6m
+29.58%
|
$452.9m
+29.55%
|
$564.7m
+24.69%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $318.1m | $335.4m | $375.4m | $445.8m | $368.8m | $517.2m | $365.9m | $463.0m | $596.6m | $759.1m | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $70.5m | $79.1m | $83.1m | $87.1m | $84.6m | $105.0m | $94.9m | $111.0m | $140.9m | $192.9m | — | |
| Depreciation, Depletion and Amortization | $172.6m | $183.8m | $199.7m | $218.7m | $243.0m | $256.6m | $243.6m | $273.9m | $299.6m | $327.9m | $346.5m | |
| Depreciation | $102.3m | $111.8m | $124.2m | $130.0m | $151.1m | $166.2m | $187.3m | $215.7m | $245.1m | $273.9m | $299.6m | |
| Amortization of Debt Issuance Costs and Discounts | $13.8m | $8.7m | $4.0m | $4.5m | $7.2m | $7.8m | $9.7m | $9.5m | $9.7m | $9.6m | — | |
| Amortization of Intangible Assets | $48.5m | $49.3m | $51.4m | $58.4m | $59.8m | $56.4m | $28.8m | $32.5m | $28.8m | $28.3m | — | |
| Deferred Income Tax Expense (Benefit) | $132.9m | $75.6m | ($9.1m) | $40.0m | $52.4m | $27.8m | $27.9m | $3.9m | $10.7m | $22.3m | $22.4m | |
| Share-based Payment Arrangement, Noncash Expense | $27.4m | $47.7m | $85.9m | $114.4m | $29.5m | $32.8m | $29.2m | $50.6m | $48.3m | $56.5m | $58.0m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $11.6m | — | $8.3m | $16.6m | $15.7m | $16.4m | $7.3m | $8.2m | $12.1m | $20.0m | — | |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | — | — | — | $48.3m | $56.5m | $58.0m | |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | — | — | — | — | — | — | — | — | ($17.4m) | ($2.7m) | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | — | |
| Income (Loss) from Equity Method Investments | $9.8m | $8.0m | $8.7m | $6.7m | $3.5m | $4.0m | $2.9m | $3.2m | $3.0m | $4.3m | — | |
| Other Nonoperating Income (Expense) | $2.9m | $4.1m | $2.2m | $30.5m | $10.6m | $12.3m | ($5.2m) | $15.7m | $20.1m | $18.8m | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $127.5m | $83.9m | ($7.0m) | $22.9m | $38.1m | $64.3m | $16.9m | $22.4m | ($3.0m) | $15.2m | ($62.9m) | |
| Accounts receivable | ($127.5m) | ($83.9m) | $7.0m | ($22.9m) | ($38.1m) | ($64.3m) | ($16.9m) | ($22.4m) | $3.0m | ($15.2m) | ($62.9m) | |
| Increase (Decrease) in Accounts Payable | $6.3m | $7.5m | $6.6m | ($6.1m) | $13.6m | $14.9m | $2.3m | $11.8m | $3.0m | ($22.6m) | $200k | |
| Net Cash Provided by (Used in) Operating Activities | $634.4m |
$657.2m
+3.59%
|
$762.4m
+16.01%
|
$635.3m
-16.67%
|
$704.7m
+10.92%
|
$715.8m
+1.58%
|
$705.8m
-1.40%
|
$850.8m
+20.54%
|
$1.0b
+17.87%
|
$1.2b
+17.23%
|
$1.2b
+1.37%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $177.7m | $225.8m | $254.5m | $372.4m | $396.0m | $528.9m | $564.8m | ($583.1m) | ($642.5m) | ($736.4m) | ($799.1m) | |
| Payments to Acquire Businesses, Net of Cash Acquired | $48.1m | $38.8m | $143.9m | $231.5m | $1.1m | $118.6m | $0 | — | — | — | — | |
| Payments for (Proceeds from) Other Investing Activities | $1.6m | $3.0m | $8.8m | $6.5m | $2.1m | ($12.5m) | $4.2m | ($3.3m) | $7.2m | $16.6m | — | |
| Net Cash Provided by (Used in) Investing Activities | ($245.0m) | ($284.5m) | ($424.5m) | ($657.4m) | ($407.5m) | ($666.3m) | ($627.0m) | ($602.8m) | ($653.3m) | ($764.6m) | ($826.4m) | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | $202.1m | $129.9m | $20.6m | $519.5m | — | — | — | — | — | — | ($1.2b) | |
| Gain (Loss) on Extinguishment of Debt | ($7.4m) | ($10.7m) | $0 | ($7.7m) | ($2.3m) | ($1.0m) | ($1.4m) | $0 | ($600k) | $0 | — | |
| Payments for Repurchase of Common Stock | $65.6m | $38.1m | $0 | $45.9m | $6.1m | $0 | $0 | — | $31.1m | $158.0m | — | |
| Payments of Ordinary Dividends, Common Stock | $83.8m | $91.5m | $100.8m | $108.7m | $111.9m | $112.4m | $99.0m | $60.4m | $62.8m | $71.1m | ($75.2m) | |
| Proceeds from (Payments for) Other Financing Activities | $8.8m | $400k | $6.1m | ($8.3m) | $1.0m | $700k | $300k | $1.2m | $2.1m | ($2.8m) | — | |
| Net Cash Provided by (Used in) Financing Activities | ($410.5m) |
($358.8m)
+12.59%
|
($321.2m)
+10.48%
|
$48.2m
+115.01%
|
($145.9m)
-402.70%
|
($240.1m)
-64.56%
|
($145.7m)
+39.32%
|
($197.2m)
-35.35%
|
($330.6m)
-67.65%
|
($431.2m)
-30.43%
|
($390.0m)
+9.55%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $16.7m | $26.1m | $151.3m | ($190.6m) | ($66.9m) | $50.8m | $18.9m | ($20.2m) | $133.5m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $133.5m | $159.6m | $310.9m | $120.3m | $53.4m | $104.2m | $123.1m | $102.9m | $133.5m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | ($64.9m) | ($51.9m) | ($75.4m) | $155.7m | $168.4m | $168.4m | $178.4m | $147.7m | $146.8m | $133.1m | — | |
| Income Taxes Paid, Net | ($11.6m) | ($19.8m) | ($8.3m) | ($16.6m) | ($15.7m) | ($16.4m) | ($7.3m) | ($8.2m) | ($12.1m) | $124.0m | — | |
| Additional Financial Items | ||||||||||||
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | $3.3m | — | — | — | — | — | — | — | — | — | — | |
| Equity Securities, FV-NI, Gain (Loss) | — | — | — | — | — | — | — | — | $1.0m | $2.5m | — | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | $1.7m | $1.2m | $400k | $600k | ($7.4m) | $1.3m | $1.0m | $2.1m | — | |
| General and Administrative Expense | $133.4m | $171.7m | $220.2m | $247.0m | $155.5m | $197.3m | $154.3m | $201.7m | $209.2m | $236.2m | — | |
| Goodwill | $1.9b | $2.0b | $2.1b | $2.3b | $2.3b | $2.4b | $1.3b | $1.3b | $1.3b | $1.3b | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $247.6m | $256.7m | $291.2m | $359.3m | $284.2m | $412.6m | $257.1m | $364.0m | $458.5m | $567.2m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $318.1m | $335.8m | $374.3m | $446.4m | $368.8m | $517.6m | $350.7m | $475.0m | $599.4m | $760.1m | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $0 | ($400k) | $1.1m | ($600k) | $0 | ($400k) | $15.2m | ($12.0m) | ($2.8m) | ($1.0m) | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $0 | ($400k) | $1.1m | ($600k) | $0 | ($400k) | $13.9m | ($12.0m) | ($2.8m) | ($1.0m) | — | |
| Income Tax Expense (Benefit) | $163.9m | $160.6m | $118.9m | $115.9m | $103.8m | $139.6m | $100.1m | $132.2m | $150.2m | $192.9m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $137.4m | $123.2m | — | |
| Proceeds from Contributions from Affiliates | — | $20.8m | $12.6m | $15.9m | $34.9m | $57.2m | $64.1m | $68.3m | $140.4m | $1.8m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.